mercaptoethanol has been researched along with Cystic Fibrosis of Pancreas in 4 studies
Mercaptoethanol: A water-soluble thiol derived from hydrogen sulfide and ethanol. It is used as a reducing agent for disulfide bonds and to protect sulfhydryl groups from oxidation.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (50.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Heaf, DP | 1 |
Webb, GJ | 1 |
Matthew, DJ | 2 |
Weller, PH | 1 |
Ingram, D | 1 |
Preece, MA | 1 |
Grasemann, H | 1 |
Gaston, B | 1 |
Fang, K | 1 |
Paul, K | 1 |
Ratjen, F | 1 |
Corradi, M | 1 |
Montuschi, P | 1 |
Donnelly, LE | 1 |
Pesci, A | 1 |
Kharitonov, SA | 1 |
Barnes, PJ | 1 |
2 trials available for mercaptoethanol and Cystic Fibrosis of Pancreas
Article | Year |
---|---|
Controlled trial of intermittent aerosol therapy with sodium 2-mercaptoethane sulphonate in cystic fibrosis.
Topics: Adolescent; Aerosols; Child; Clinical Trials as Topic; Cystic Fibrosis; Double-Blind Method; Female; | 1980 |
Increased nitrosothiols in exhaled breath condensate in inflammatory airway diseases.
Topics: Adult; Aged; Asthma; Biomarkers; Breath Tests; Cystic Fibrosis; Female; Humans; Inflammation; Lung D | 2001 |
2 other studies available for mercaptoethanol and Cystic Fibrosis of Pancreas
Article | Year |
---|---|
In vitro assessment of combined antibiotic and mucolytic treatment for Pseudomonas aeruginosa infection in cystic fibrosis.
Topics: Azlocillin; Cystic Fibrosis; Drug Therapy, Combination; Humans; Mercaptoethanol; Mesna; Penicillins; | 1983 |
Decreased levels of nitrosothiols in the lower airways of patients with cystic fibrosis and normal pulmonary function.
Topics: Adolescent; Bronchi; Bronchoalveolar Lavage Fluid; Child; Cystic Fibrosis; Humans; Mercaptoethanol; | 1999 |